NON-SMALL-CELL LUNG
Clinical trials for NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in lung cancer before surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy before surgery helps people with early-stage non-small cell lung cancer. About 453 participants received either the drug combo or a placebo with chemo, followed by surgery and possibly m…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New hope for lung cancer patients when first treatment fails
Disease control CompletedThis study tested whether adding a drug called aflibercept to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer live longer when their first treatment stops working. Over 900 participants received either the new combination or chemotherapy pl…
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 22, 2026 15:58 UTC